| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute lymphoblastic leukaemia relapse presenting as optic nerve infiltration
|
Chauhan, Khushboo
|
|
|
25 |
12 |
p. e704
|
artikel
|
| 2 |
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
|
Rugo, Hope S
|
|
|
25 |
12 |
p. e629-e638
|
artikel
|
| 3 |
American Lung Association calls for expanded insurance coverage for lung cancer screening
|
Furlow, Bryant
|
|
|
25 |
12 |
p. e627
|
artikel
|
| 4 |
Anticipating the future of cancer care in Trump's America
|
The Lancet Oncology,
|
|
|
25 |
12 |
p. 1507
|
artikel
|
| 5 |
Artificial intelligence-aided data mining of medical records for cancer detection and screening
|
Haue, Amalie Dahl
|
|
|
25 |
12 |
p. e694-e703
|
artikel
|
| 6 |
Balancing clinical benefit and social value: challenges in HTA assessments
|
Verduzco-Aguirre, Haydee
|
|
|
25 |
12 |
p. 1518-1519
|
artikel
|
| 7 |
Cancer care and outreach in South Asian Association for Regional Cooperation (SAARC) countries: from epidemiology and the National Cancer Control Programme to screening, diagnosis, and treatment
|
Huq, M Saiful
|
|
|
25 |
12 |
p. e639-e649
|
artikel
|
| 8 |
Cancer care and outreach in the South Asian Association for Regional Cooperation (SAARC) region: overcoming barriers and addressing challenges
|
Huq, M Saiful
|
|
|
25 |
12 |
p. e650-e662
|
artikel
|
| 9 |
Cancer care, education, and research in the South Asian Association for Regional Cooperation (SAARC) countries
|
Reeves, Cheryl
|
|
|
25 |
12 |
p. 1524-1525
|
artikel
|
| 10 |
Cancer education and training within the South Asian Association for Regional Cooperation (SAARC) countries
|
Huq, M Saiful
|
|
|
25 |
12 |
p. e663-e674
|
artikel
|
| 11 |
Cancer prevention, care, and outreach among the Rohingya refugee population in Bangladesh
|
Chowdhury, Mohiuddin A K
|
|
|
25 |
12 |
p. 1533-1536
|
artikel
|
| 12 |
Cancer research in South Asian Association for Regional Cooperation (SAARC) countries
|
Huq, M Saiful
|
|
|
25 |
12 |
p. e675-e684
|
artikel
|
| 13 |
Capturing the true effect of anti-PD-1 therapy on patients’ health-related quality of life
|
Egeler, Mees D
|
|
|
25 |
12 |
p. e617
|
artikel
|
| 14 |
Capturing the true effect of anti-PD-1 therapy on patients’ health-related quality of life – Authors' reply
|
Bührer, Emanuel
|
|
|
25 |
12 |
p. e618
|
artikel
|
| 15 |
Challenging cancer through poetry
|
Mellor, Daniel
|
|
|
25 |
12 |
p. 1537
|
artikel
|
| 16 |
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis
|
Mastrantoni, Luca
|
|
|
25 |
12 |
p. 1655-1665
|
artikel
|
| 17 |
Correction to Lancet Oncol 2024; 25: 1176–87
|
|
|
|
25 |
12 |
p. e626
|
artikel
|
| 18 |
Correction to Lancet Oncol 2024; 25: 1188–201
|
|
|
|
25 |
12 |
p. e626
|
artikel
|
| 19 |
Correction to Lancet Oncol 2023; 24: 1181–95
|
|
|
|
25 |
12 |
p. e626
|
artikel
|
| 20 |
Correction to Lancet Oncol 2024; 25: e581–88
|
|
|
|
25 |
12 |
p. e626
|
artikel
|
| 21 |
Decentralised clinical trials: a game changer for improved access to clinical trials
|
Underhill, Craig
|
|
|
25 |
12 |
p. e625
|
artikel
|
| 22 |
Early switch maintenance in gastric cancer: who benefits most?
|
Sakakida, Tomoki
|
|
|
25 |
12 |
p. 1508-1509
|
artikel
|
| 23 |
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study
|
Miller, Sean
|
|
|
25 |
12 |
p. 1666-1676
|
artikel
|
| 24 |
European Commission highlights policies to support return to work for patients with cancer and survivors
|
Burki, Talha
|
|
|
25 |
12 |
p. 1527
|
artikel
|
| 25 |
Final phase of HPV vaccination campaign launched in Bangladesh
|
Samarasekera, Udani
|
|
|
25 |
12 |
p. 1528
|
artikel
|
| 26 |
Former big tobacco employee no longer part of UK Government cancer advisory committee
|
Kirby, Tony
|
|
|
25 |
12 |
p. e628
|
artikel
|
| 27 |
Group of UK MPs urge colleagues to support assisted dying bill
|
Devi, Sharmila
|
|
|
25 |
12 |
p. 1530
|
artikel
|
| 28 |
Helping men to talk—and laugh—about cancer
|
Ranscombe, Peter
|
|
|
25 |
12 |
p. 1538
|
artikel
|
| 29 |
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial
|
Classe, Jean-Marc
|
|
|
25 |
12 |
p. 1551-1562
|
artikel
|
| 30 |
Impact of radiopharmaceutical shortage prompts questions on UK resilience
|
Wilkinson, Emma
|
|
|
25 |
12 |
p. 1529
|
artikel
|
| 31 |
Investing in cancer care in the UK: why aren't we acting on the evidence?
|
Ward, Zachary J
|
|
|
25 |
12 |
p. 1522-1524
|
artikel
|
| 32 |
Locoregionally advanced nasopharyngeal carcinoma: integrating immunotherapy into definitive treatment
|
Kwong, Dora L W
|
|
|
25 |
12 |
p. 1511-1513
|
artikel
|
| 33 |
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health
|
Arisa, Oluwatobi T
|
|
|
25 |
12 |
p. e685-e693
|
artikel
|
| 34 |
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
|
Liu, Sai-Lan
|
|
|
25 |
12 |
p. 1563-1575
|
artikel
|
| 35 |
New funding for Indigenous-led cancer research and nationwide clinical trials in Australia
|
Kirby, Tony
|
|
|
25 |
12 |
p. 1526
|
artikel
|
| 36 |
New Zealand doctors raise alarm about cancer drugs inequity
|
Kirby, Tony
|
|
|
25 |
12 |
p. 1531
|
artikel
|
| 37 |
Palliative radiotherapy for hepatic cancer pain
|
Xiang, Ze
|
|
|
25 |
12 |
p. e619
|
artikel
|
| 38 |
Palliative radiotherapy for hepatic cancer pain
|
Wong, Chi Yan
|
|
|
25 |
12 |
p. e620
|
artikel
|
| 39 |
Palliative radiotherapy for hepatic cancer pain
|
Bian, Saiyan
|
|
|
25 |
12 |
p. e621
|
artikel
|
| 40 |
Palliative radiotherapy for hepatic cancer pain
|
Liang, Xianwen
|
|
|
25 |
12 |
p. e622
|
artikel
|
| 41 |
Palliative radiotherapy for hepatic cancer pain – Authors' reply
|
Dawson, Laura A
|
|
|
25 |
12 |
p. e623-e624
|
artikel
|
| 42 |
Patients with head and neck cancer unfit for cisplatin—what next?
|
Kiyota, Naomi
|
|
|
25 |
12 |
p. 1513-1514
|
artikel
|
| 43 |
Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment
|
Forrest, Robin
|
|
|
25 |
12 |
p. 1635-1643
|
artikel
|
| 44 |
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
|
Mell, Loren K
|
|
|
25 |
12 |
p. 1576-1588
|
artikel
|
| 45 |
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial
|
Randon, Giovanni
|
|
|
25 |
12 |
p. 1539-1550
|
artikel
|
| 46 |
Retraction and republication—Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
|
The Editors of The Lancet Oncology,
|
|
|
25 |
12 |
p. 1521-1522
|
artikel
|
| 47 |
Retrospective analysis of immunotherapy outcomes in Black patients
|
Reynolds, Kerry L
|
|
|
25 |
12 |
p. 1519-1521
|
artikel
|
| 48 |
Secondary cytoreductive surgery with HIPEC: a promising therapeutic option for recurrent ovarian cancer
|
May, Taymaa
|
|
|
25 |
12 |
p. 1509-1511
|
artikel
|
| 49 |
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
|
Vora, Sujay
|
|
|
25 |
12 |
p. 1625-1634
|
artikel
|
| 50 |
The current and future global burden of cancer among adolescents and young adults: a population-based study
|
Hughes, Taylor
|
|
|
25 |
12 |
p. 1614-1624
|
artikel
|
| 51 |
The power of three: hypofractionation, protons, and molecular imaging in glioblastoma radiotherapy
|
Mellon, Eric A
|
|
|
25 |
12 |
p. 1514-1516
|
artikel
|
| 52 |
The trade-off between accelerated cancer drug approvals and patient preferences
|
Trapani, Dario
|
|
|
25 |
12 |
p. 1516-1517
|
artikel
|
| 53 |
UK Government introduces Tobacco and Vapes Bill
|
Burki, Talha
|
|
|
25 |
12 |
p. 1532
|
artikel
|
| 54 |
Use of the ESMO-Magnitude of Clinical Benefit Scale to guide HTA recommendations on coverage and reimbursement for cancer medicines: a retrospective analysis
|
Kanavos, Panos
|
|
|
25 |
12 |
p. 1644-1654
|
artikel
|
| 55 |
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
|
Zinzani, Pier Luigi
|
|
|
25 |
12 |
p. 1602-1613
|
artikel
|
| 56 |
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study
|
Maruyama, Dai
|
|
|
25 |
12 |
p. 1589-1601
|
artikel
|
Tijdschrift beschrijving